Disgruntled Nobel loser sues; brain trauma researchers search for biomarker of a chronic condition; receptor for novel coronavirus found; the rise of transcriptomics; and ethical oversight of participant-led research
Advertisement
The Scientist
Most Recent
A surgeon sues the Nobel Assembly for excluding him from last year’s prize awarded for regenerative science, but stem cell scientists are skeptical of his claims.
Researchers identify the target protein of a recently discovered human coronavirus, shedding light on infection and possible interspecies spread.
Tailoring ethical oversight to participant-led research
Native Australian frog tadpoles outcompete the tadpoles of the invasive cane toad, suggesting the native frogs could form part of a suburban control program.
Although fully organized patient-run trials are still few and far between, patients are taking a more active role in clinical research.
Patients are sidestepping clinical research and using themselves as guinea pigs to test new treatments for fatal diseases. Will they hurt themselves, or science?
The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.
New research adds to an emerging picture of the changes that global warming and thinning ice are wreaking on the marine ecosystems at the top of the world.
Scenes from a research trip, where researchers peered beneath the ice to shine a light on the emerging picture of a changing Arctic Ocean
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
